Erschienen in:
01.04.2004 | Adis Drug Profile
Ethinylestradiol/Chlormadinone Acetate
A Viewpoint by Ulrich Winkler
verfasst von:
Ulrich Winkler
Erschienen in:
Drugs
|
Ausgabe 7/2004
Einloggen, um Zugang zu erhalten
Excerpt
Ethinylestradiol/chlormadinone acetate (EE/CMA) 0.03/2 mg/day is a new monophasic oral contraceptive that combines the advantages of a low-dose EE preparation with high efficacy in the treatment of acne, seborrhoea, alopecia and hirsutism. Published data on exposure to EE/CMA in 22 337 cycles reveal good contraceptive efficacy, with an adjusted Pearl index of 0.27. …